Aerovate Therapeutics Organization
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Connections from
Founded Date:
2019
Employee Number:
1-10
Technology:
Anti-infective Drugs
Last Funding Type:
Series A
Investor Type:
Healthcare Company
Headquarters:
Boston, Massachusetts, United States
Total Funding:
72600000
Funding Status:
IPO
Industry:
PharmTech